Eduardo Rene Salas

Director, Intra-Cellular Therapies, Inc.

Companies

ADMA Biologics (United States)Board member Jan 2, 2025 to now¹
Intra-Cellular Therapies, Inc.Board member Apr 21, 2022 to Apr 2, 2025²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

ADMA Biologics (United States) ADMA21,579 shares³$239.2K at $11.09Feb 9, 2026
Intra-Cellular Therapies, Inc.0 shares⁴Apr 2, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 9, 2026Granted 10,690 shares of ADMA Biologics (United States)³
Apr 2, 2025Returned to company 1,567 shares at $132.00 of Intra-Cellular Therapies, Inc.⁴
Feb 19, 2025Granted 10,889 shares of ADMA Biologics (United States)⁵
Jun 23, 2024Exercised options 1,567 shares of Intra-Cellular Therapies, Inc.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARADMA Biologics (United States), Board member
2
SEC EDGARIntra-Cellular Therapies, Inc., Board member
3
SEC EDGARADMA Biologics (United States) shares after the filing of Feb 9, 2026
4
SEC EDGARIntra-Cellular Therapies, Inc. shares after the filing of Apr 2, 2025
5
SEC EDGARForm 4 filed Feb 21, 2025
6
SEC EDGARForm 4 filed Jun 25, 2024